Notice to Employees of AstraZeneca Pharmaceuticals LP and AstraZeneca LP

This document is about a notice to employees of AstraZeneca Pharmaceuticals LP and AstraZeneca LP regarding an application for authorization under Prohibited Transaction Exemption 96-62 to allow the reinsurance of risks and receipt of premiums by AZ-Mont Insurance Company, AstraZeneca's captive insurance company, for the business travel accident insurance benefits offered under the AstraZeneca Business Travel Accident Insurance Plan. The notice outlines the proposed transaction, the parties involved, the benefit improvements that will be provided, and the employee's right to comment on the tentative authorization.